{"pmid":32303733,"title":"How research funders are tackling coronavirus disruption.","text":["How research funders are tackling coronavirus disruption.","Nature","Stoye, Emma","32303733"],"journal":"Nature","authors":["Stoye, Emma"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32303733","week":"202016|Apr 13 - Apr 19","doi":"10.1038/d41586-020-01120-2","source":"PubMed","topics":["General Info"],"weight":1,"_version_":1664431720521269248,"score":8.233237,"similar":[{"pmid":32193300,"title":"Coronavirus disruptions reverberate through research.","text":["Coronavirus disruptions reverberate through research.","Science","Servick, Kelly","Cho, Adrian","Couzin-Frankel, Jennifer","Guglielmi, Giorgia","32193300"],"journal":"Science","authors":["Servick, Kelly","Cho, Adrian","Couzin-Frankel, Jennifer","Guglielmi, Giorgia"],"date":"2020-03-21T11:00:00Z","year":2020,"_id":"32193300","week":"202012|Mar 16 - Mar 22","doi":"10.1126/science.367.6484.1289","source":"PubMed","topics":["General Info"],"weight":1,"_version_":1663352133537234944,"score":57.39985},{"pmid":32267613,"title":"Research disruptions and recovery.","text":["Research disruptions and recovery.","With the pandemic of COVID-19, the routine work of surgeons has been reduced to release resources to critical care and other functions. This is necessary and right, in order to protect the health of our communities now. As a consequence, many of us who undertake clinical research have seen our work suspended. With a rich portfolio of colorectal research, this includes studies such as ROSSINI2, PITSTOP, & MASH, and has delayed the start of other important studies such as ELF 2 and Damascus]. When we return to something akin to normality, we shall be looking to re-establish the studies in a timely manner. Funders have generally been flexible with regards to the disruption and have provided guidance on how the disruption might be managed(1) . There is no doubt that they may be asked to provide additional support for studies in progress, which may impact future funding opportunities.","Colorectal Dis","Lee, Matthew","Brown, Steven","Moug, Susan","Vimalachandran, Dale","Acheson, Austin","32267613"],"abstract":["With the pandemic of COVID-19, the routine work of surgeons has been reduced to release resources to critical care and other functions. This is necessary and right, in order to protect the health of our communities now. As a consequence, many of us who undertake clinical research have seen our work suspended. With a rich portfolio of colorectal research, this includes studies such as ROSSINI2, PITSTOP, & MASH, and has delayed the start of other important studies such as ELF 2 and Damascus]. When we return to something akin to normality, we shall be looking to re-establish the studies in a timely manner. Funders have generally been flexible with regards to the disruption and have provided guidance on how the disruption might be managed(1) . There is no doubt that they may be asked to provide additional support for studies in progress, which may impact future funding opportunities."],"journal":"Colorectal Dis","authors":["Lee, Matthew","Brown, Steven","Moug, Susan","Vimalachandran, Dale","Acheson, Austin"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267613","week":"202015|Apr 06 - Apr 12","doi":"10.1111/codi.15069","source":"PubMed","locations":["Damascus"],"countries":["Syrian Arab Republic"],"countries_codes":["SYR|Syrian Arab Republic"],"weight":0,"_version_":1663609715856244736,"score":45.057186}]}